Trial NCT00251589

View at ClinicalTrials.gov 
Org. Study IDs: 0683-025
Secondary IDs: 2005_080 MK0683-025

Last trial update was posted on 2015-03-06

MeSH Interventions

Erlotinib Hydrochloride Vorinostat

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions


Stopping Reasons

This trial is being closed based on lack of substantive efficacy, slow accrual and overall tolerance in patients treated to date.

Limitations And Caveats

Due to the slow pace of patient accrual, failure to observe meaningful efficacy in treated patients, and overall intolerance of the combination regimen, the study was terminated prematurely on 12-Oct-2007.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID